🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Repetitive levosimendan infusions for patients with advanced chronic heart ...
Status
Unknown
Location
Medical University Innsbruck
Start Date
2018-03-08
Trial ID
NCT03437226
Treatments Being Tested
The purpose of this study is to evaluate the efficacy of rilematovir compar...
Status
Terminated
Location
Central Alabama Research
Start Date
2021-11-17
Trial ID
NCT04978337
Treatments Being Tested
This is a randomized, placebo-controlled, 2-period crossover, escalating re...
Status
Completed
Location
GSK Investigational Site
Start Date
2017-02-09
Trial ID
NCT02991859
A Phase 1 study will test the safety, tolerability and pharmacokinetics of ...
Status
Completed
Location
Nucleus Network Limited
Start Date
2016-07-26
Trial ID
NCT03096756
The use of systemic antibiotics as and adjunct to non-surgical peri-implant...
Status
Completed
Location
Department of periodontology, faculty of Odontology
Start Date
2018-03-03
Trial ID
NCT03564301
Treatments Being Tested
The objective of this study is to evaluate the safety and tolerability of V...
Status
Completed
Location
Luitpold Pharmaceuticals
Start Date
2005-07
Trial ID
NCT00740246
The purpose of this study is to determine in current and non-smokers the cl...
Status
Completed
Location
Department of Periodontology
Start Date
2003-07
Trial ID
NCT00066066
Treatments Being Tested
This is a 3-part study to evaluate the safety, tolerability, pharmacokineti...
Status
Completed
Location
Multiple Locations
Start Date
2016-08-13
Trial ID
NCT02852395
Treatments Being Tested
In this study, the safety and pharmacokinetics of 10 % terbinafine hydrogen...
Status
Completed
Location
TKL Research Inc.
Start Date
2005-02
Trial ID
NCT00691184
Treatments Being Tested
Part 1: This is a Phase 1b, randomized, double-blind, crossover, dose escal...
Status
Terminated
Location
Spaulding Clinical Research, LLC
Start Date
2023-03-12
Trial ID
NCT05906732
Treatments Being Tested